In this issue:
- Cancer outcomes without upfront surgery for DCIS
- Risk-reducing surgeries in young BRCA carriers with breast cancer
- Disparities in time to breast cancer surgery by deprivation
- Adjuvant endocrine therapy and long-term outcomes from DCIS
- Breastfeeding after HR+ breast cancer
- Inavolisib in PIK3CA mutated advanced breast cancer
- Statin use and breast cancer-specific mortality and recurrence
- Younger women’s wellness after cancer programme
- Cardio-protection for anthracycline-treated breast cancer
- Reduced duration adjuvant trastuzumab for HER2 positive breast cancer
Please login below to download this issue (PDF)